Skip to main content
Europlasma logo

Europlasma — Investor Relations & Filings

Ticker · ALEUP ISIN · FR001400CF13 LEI · 969500WYVNHBV1ABQ250 Euronext Growth Water supply; sewerage, waste management and remediation activities
Open in API
Filings indexed 506 across all filing types
Latest filing 2024-02-06 Declaration of Voting R…
Country FR France
Listing Euronext Growth ALEUP

About Europlasma

https://www.europlasma.com/en/

Europlasma is a company specializing in clean technology and energy solutions. Its core activities focus on the research, engineering, and application of plasma solutions for industrial purposes, particularly for the treatment of hazardous waste and gas. The company provides services for the destruction and valorization of asbestos waste. In the decarbonization sector, Europlasma transforms waste into Solid Recovered Fuel (SRF). Additionally, the company operates an industrial division that manufactures hollow bodies and anodized sheets for capacitors.

Recent filings

Filing Released Lang Actions
EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 31 janvier 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release dated February 6, 2024, titled "Information relative au nombre total de droits de vote et d'actions composant le capital au 31 janvier 2024" (Information relating to the total number of voting rights and shares comprising the capital as of January 31, 2024). It explicitly states the total number of shares and voting rights as required by French commercial code (L. 233-8 II) and AMF regulations (223-16). This type of mandatory disclosure regarding the capital structure and voting rights is typically classified under notifications related to share capital changes or major shareholdings, but given the specific options, it most closely aligns with a notification about the capital structure or a general regulatory filing. Since it is a formal declaration of the total number of shares and voting rights, it is a specific type of capital structure update. However, none of the codes perfectly match 'Total Voting Rights Disclosure'. Comparing the definitions: 'SHA' (Share Issue/Capital Change) is close, but this is a periodic disclosure, not an issuance announcement. 'MRQ' (Major Shareholding Notification) is for changes in ownership thresholds. Given the context of mandatory periodic disclosure of capital structure details, and lacking a specific 'Voting Rights Disclosure' code, this falls under a general regulatory announcement. Since it is a formal, periodic disclosure required by regulators, and it doesn't fit perfectly into SHA or MRQ, it is best categorized as a Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if interpreted broadly. However, the content is purely about the count of shares/votes, which is a standard regulatory reporting requirement. Given the options, RNS is the most appropriate fallback for a mandatory regulatory disclosure that doesn't fit a more specific category like DIV or SHA.
2024-02-06 French
EUROPLASMA: Dépôt d’une offre de reprise globale de MG-Valdunes
M&A Activity Classification · 99% confidence The document is a press release ("Communiqué de presse") dated February 1, 2024, announcing that Europlasma has filed a takeover bid ("offre de reprise globale en plan de cession") for MG-Valdunes, a company in receivership. This announcement details a significant corporate transaction (M&A activity) involving a takeover bid and subsequent industrial plan, including financial tables related to the target company and conditions for the transaction. This clearly falls under the category of M&A Activity (TAR), which covers merger proposals or takeover bids. It is not a standard regulatory report like a 10-K or IR, nor is it a short announcement of a report (RPA/RNS).
2024-02-01 French
EUROPLASMA: TIRAGE D’UNE TRANCHE DE 200 OCEANE
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated January 29, 2024, announcing the drawdown ('tirage') of a tranche of convertible bonds (OCEANE) for one million euros under a previously established financing agreement with EPF. The text heavily discusses the mechanics of this financing, the associated risks (dilution, share price pressure), and potential future capital structure adjustments (share consolidation, nominal value reduction). This activity directly relates to the company raising capital or changing its financing structure. This aligns best with the 'Capital/Financing Update' category (CAP). It is not a full Annual Report (10-K), an Earnings Release (ER), or a simple Dividend Notice (DIV). Since it is a detailed announcement about a specific financing event, CAP is the most appropriate classification.
2024-01-29 French
EUROPLASMA: Informations relatives à l’offre de reprise de MG-Valdunes présentée par Europlasma
Legal Proceedings Report Classification · 99% confidence The document is a press release ("Communiqué de presse") dated January 25, 2024, detailing an update regarding a takeover offer ("offre de reprise") for MG-Valdunes and Europlasma's request for an extension. It discusses corporate actions, potential financing implications (mentioning convertible bonds and dilution risk), and future market communication. This type of announcement, which is not a full financial report (like 10-K or IR), a formal earnings release (ER), or a specific regulatory filing like DIRS or DIV, fits best under the general category for significant corporate news that impacts investors. Since it is a press release providing material, non-financial-statement-specific updates, it is classified as a Regulatory Filing (RNS) as the most appropriate general category for material, non-standardized announcements, or potentially Capital/Financing Update (CAP) due to the detailed discussion of financing instruments and dilution risk. Given the primary focus is an update on a corporate transaction/offer status and general market communication, RNS is the safest general regulatory announcement category, although CAP is also relevant. I will lean towards RNS as the primary classification for a general press release updating the market on a corporate situation that isn't strictly about capital raising itself, but rather a transaction update.
2024-01-25 French
EUROPLASMA: Précisions relatives aux les informations parues dans les médias
M&A Activity Classification · 99% confidence The document is a press release dated January 11, 2024, issued by Europlasma. It addresses media reports regarding a potential acquisition (the Leffrinckoucke forge) and states that the information is not yet precise enough for a formal communication, promising to inform the market if the situation evolves. It also contains standard 'About Us' information, contact details, and a detailed 'Warning' section discussing forward-looking statements and risks associated with existing financing agreements (convertible bonds leading to potential dilution). This type of communication, which addresses market rumors or provides timely, non-periodic operational/strategic updates outside of formal financial reports (like 10-K or IR), most closely aligns with a general regulatory announcement or a specific update that doesn't fit the other categories. Since it is a direct communication to the market regarding potential corporate activity and market perception, and it is not a full financial report, earnings release, or a specific transaction report (like DIRS or DIV), it falls best under the general 'Regulatory Filings' (RNS) category as a miscellaneous, timely market disclosure, or potentially a Capital/Financing Update (CAP) due to the extensive discussion of dilutive financing, but RNS is a safer general fit for press releases addressing market rumors/updates. Given the content focuses heavily on addressing rumors about M&A activity and detailing risks related to existing financing structures, it is a specific market disclosure. It is not an ER, IR, 10-K, or MDA. It is a press release providing material, non-scheduled information. Therefore, RNS (Regulatory Filings) is the most appropriate fallback for this type of ad-hoc market communication.
2024-01-11 French
EUROPLASMA: Autorisation de traiter les crasses d’aluminium délivrée par les autorités chinoises
Regulatory Filings Classification · 95% confidence The document is a press release dated January 9, 2024, announcing that a Chinese subsidiary received a permit to process aluminum dross. It discusses a future joint-venture agreement and mentions an upcoming accounting audit. This is a specific operational and strategic update, not a full financial report (like 10-K or IR), a formal earnings release (ER), or a management discussion (MDA). Since it announces a significant development related to operations, partnerships, and regulatory milestones, it is best classified as a general Regulatory Filing (RNS) as it is a broad announcement that doesn't fit the more specific categories like M&A (TAR) or Capital Change (CAP). Given its nature as a press release detailing a significant operational milestone, RNS is the most appropriate fallback, although it contains elements of business updates.
2024-01-09 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.